Mikhail Blagosklonny is a scientist who has contributed immensely to the study of cancer treatment and aging. Mikhail got his education from Pavlov State University, St. Peterburg. He was an associate professor of medicine at New York Medical College, Valhalla, New York. He then became a senior scientist at Ordway Research Institute in Albany, New York. In 2009 went to be a professor at Roswell Park Cancer Institute in Buffalo, New York.
His contributions to science are unique to cancer topics like, molecular and cellular biology investigations that help clinically in treating malignancy of cells. He draws his attention towards oncogenes and tumor suppressors, signal transduction, cell cycle, mitosis, apoptosis, therapies suppressing cancer while emphasizing on the translation of basic sciences to help fight the cancer menace. He is striving towards exploiting and disrupting the cancer cell cycling, drug resistance for the protection of normal cells while targeting malignant zombie cells.
Mikhail is also focused on anti-aging. He has extended his research on getting things that affect aging and cause age-related diseases. His effort has led to some anti-aging drugs like the rapamycin that can be used by individuals who do not want to age. Mikhail Blagosklonny has created a school of thought that TOR signaling has a role in aging and cancer. He has proposed that the cancer drug, rapamycin can be used as a longevity drug and is passionate about this. He says that the drug can extend a person’s lifespan.
Mikhail has contributed to books and is an author of several scientific books. He writes on hyper-chemotherapeutic engineering and cell cyclotherapy. So far he has published more than 300 research articles, reviews, and book chapters. He is the founding editor and editor-in-chief of Cell Cycle and has co-edited and co-founded the Aging, Oncotarget, and Oncoscience. He served as an Associate Editor for Cancer Biology and Therapy, Autophagy, Cancer Research, Cell Death and Differentiation, The American Journal of Pathology, PLOS ONE and International Journal of Cancer.
His contribution to life and cell aging cannot be undermined. Mikhail Blagoskonny has continuously been making positive developments that people who have cancer can use and be cured. Visit ResearchGate.Net to learn more about Mikhail’s latest work.